Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immunome, Inc. - Common Stock (NQ:IMNM)

8.640 -0.310 (-3.46%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immunome, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Immunome Provides Update on Investigational New Drug Application for IMM-BCP-01 for the Treatment of COVID-19
From Immunome, Inc.
Via Business Wire
Immunome to Participate in Fireside Chat Hosted by Cantor Fitzgerald
From Immunome, Inc.
Via Business Wire
The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Adcom Backing For Oral COVID-19 Antiviral Medication Molnupiravir... 
Via Benzinga
Topics Intellectual Property
Immunome Expects IMM-BCP-01 Antibody Cocktail To Neutralize the SARS-CoV-2 Omicron Variant
From Immunome, Inc.
Via Business Wire
Why Are Immunome Shares Trading Higher Today?
Immunome Inc (NASDAQ: IMNM) has submitted an Investigational New Drug (IND) application to the FDA for IMM-BCP-01, a three-antibody cocktail, for the treatment of COVID-19. IMM-... 
Via Benzinga
Immunome Announces Submission of an Investigational New Drug (IND) Application for IMM-BCP-01 for the Treatment of COVID-19
From Immunome, Inc.
Via Business Wire
Immunome Reports Third Quarter 2021 Financial Results
From Immunome, Inc.
Via Business Wire
Immunome to Present at the Stifel Healthcare Conference
From Immunome, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 29, 2021
Upgrades For Preferred Bank (NASDAQ: 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Ocugen (NASDAQ:OCGN) stock increased by 31.15% to $12.25 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.4 billion.... 
Via Benzinga
64 Biggest Movers From Yesterday
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 83.4% to close at $5.30. Siyata Mobile released their Q2 earnings on an October 15th call that included CEO Marc... 
Via Benzinga
Immunome Announces Submission for Publication of Pre-clinical Research Detailing the Importance of Antibody Cocktail for SARS-CoV-2 Treatment and Prophylaxis
From Immunome, Inc.
Via Business Wire
Immunome Presents Compelling Preclinical Data on Anti-IL-38 Antibody Program at the American Association for Cancer Research NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
From Immunome, Inc.
Via Business Wire
54 Biggest Movers From Friday
Check out these big penny stock gainers and losers Losers Spire Global, Inc.. (NYSE: SPIR) shares fell 43.3% to close at $7.10 on Friday. Spire Global, Inc.... 
Via Benzinga
Immunome to Present Preclinical Data on Anti IL-38 Antibody Program at the American Association for Cancer Research NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
From Immunome, Inc.
Via Business Wire
Immunome to Present at the Cantor Global Healthcare Conference
From Immunome, Inc.
Via Business Wire
Immunome to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
From Immunome, Inc.
Via Business Wire
45 Stocks Moving In Monday's Mid-Day Session
Gainers Aterian, Inc. (NASDAQ: ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets. Itamar Medical Ltd. (NASDAQ: ITMR)... 
Via Benzinga
72 Biggest Movers From Yesterday
Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead... 
Via Benzinga
Immunome's COVID-19 Antibody Neutralizes Two Variant Strains In Animal Studies
Immunome Inc's (NASDAQ: IMNM) three-antibody cocktail (IMM-BCP-01) has demonstrated potent neutralizing activity against SARS-CoV-2 Lambda (C.37) and Delta AY.1/2 (Delta... 
Via Benzinga
72 Biggest Movers From Yesterday
Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth.... 
Via Benzinga
Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes SARS-CoV-2 Lambda and Delta Plus Variants in Pre-clinical Testing
From Immunome, Inc.
Via Business Wire
Immunome Reports Second Quarter 2021 Financial Results
From Immunome, Inc.
Via Business Wire
38 Stocks Moving In Wednesday's Mid-Day Session
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares jumped 218.7% to $6.57 after the company received a $28.3 million purchase order from Brazil's Bio-Manguinhos to... 
Via Benzinga
28 Stocks Moving in Wednesday's Pre-Market Session
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares rose 78.2% to $3.67 in pre-market trading after dropping more than 16% on Tuesday. Chembio’s filing recently showed... 
Via Benzinga
62 Biggest Movers From Yesterday
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received FDA breakthrough device designation for the treatment... 
Via Benzinga
Mid-Afternoon Market Update: Dow Jumps Over 600 Points; NeuroMetrix Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded up 1.83% to 34,583.56 while the NASDAQ rose 1.74% to 14,523.41. The S&P also rose, gaining 1.70% to 4,330.82. The U.S. has... 
Via Benzinga
Topics Stocks
Dow Rises 500 Points as Rally Gains Momentum
Stocks are on a tear midday, as investors shake off delta variant fears and buy the dip in the wake of yesterday's selloff. 
Via Talk Markets
Topics Stocks
34 Stocks Moving In Tuesday's Mid-Day Session
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares climbed 50.9% to $4.2550. NeuroMetrix, Inc. (NASDAQ: NURO) gained 37.4% to $4.4750 as the company said it received FDA... 
Via Benzinga
IMNM Stock: The Covid Treatment News That Has Immunome Soaring Today
IMNM stock is having a great day today. The company is preparing to move forward with expedited testing for its delta variant treatment. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.